Search This Blog

Wednesday, October 31, 2018

Orchard Therapeutics indicated to open at $18, IPO priced at $14


Orchard Therapeutics’ 14.3M share IPO priced at $14. JPMorgan, Goldman Sachs, Cowen and Wedbush are acting as joint book running managers for the offering.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)